The Methodology of Studying Decline in Alzheimer's Disease
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Objective : To present a new model for analyzing longitudinal data. The trilinear model is superior to the commonly used linear model that includes the flawed assumption that decline is uniform throughout the course of disease—an assumption that does not correspond to clinical observations. Design : A longitudinal cohort sample was used to compare the linear and trilinear models. Simulated longitudinal data were generated to assess classification errors with the trilinear model. Subjects and Setting : The subjects were 80 patients with Alzheimer's disease tested in a hospital out‐patient clinic. Methods : The trilinear model describes Alzheimer's disease as proceeding through three periods: An initial period of stability before detectable decline, a period of decline, and a final period of stability during which there is no further detectable decline. A program for the Apple Macintosh computer is available at no charge to apply the model to data. Findings : The analyses indicated that the trilinear model provides a better reflection of decline in Alzheimer's disease than does the linear model. This advantage is present whether the periods of stability reflect a “true” lack of decline or insensitivity of a measurement instrument. Conclusions : The trilinear model provides not only a more accurate estimate of the average rate of change, but also (when possible) estimates of the point at which decline begins and ends. Also, more detailed comparisons of tests could be made by using the trilinear parameters. The trilinear model would benefit researchers engaged in longitudinal research of progressive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
Davis, K. L., Thal, L. J., Gamzu, E. R., Davis, C. S., Woolson, R. F., Gracon, S. I., Drachman, D. A., Schneider, L. S., Whitehouse, P. J., Hoover, T. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271801 · Cited by 626
Cited by
Agüero‐Torres, H., Fratiglioni, L., Guo, Z., Viitanen, M., & Winblad, B. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb02464.x · Cited by 147
Prognosis of Alzheimer’s Disease: The Rotterdam Study
Ruitenberg, A., Kalmijn, S., de Ridder, M. A. J., Redekop, W. K., van Harskamp, F., Hofman, A., Launer, L. J., & Breteler, M. M. B. (2001) · Neuroepidemiology · doi:10.1159/000054786 · Cited by 41
Functional imaging predicts cognitive decline in Alzheimer's disease.
Jagust, W. J., Haan, M. N., Eberling, J. L., Wolfe, N., & Reed, B. R. (1996) · Journal of Neuroimaging · doi:10.1111/jon199663156 · Cited by 39
Metadata
- Authors
- Brooks, J. O., Kraemer, H. C., Tanke, E. D., & Yesavage, J. A.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 1993-06
- Volume
- 41
- Issue
- 6
- Pages
- 623-628
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2030500443
- Cited by
- 72
- References
- 1
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Methodology of Studying Decline in Alzheimer's Disease. https://app.cochat.ai/papers/10.1111/j.1532-5415.1993.tb06734.x
- The paper
- Brooks, J. O., Kraemer, H. C., Tanke, E. D., & Yesavage, J. A. (1993). The Methodology of Studying Decline in Alzheimer's Disease. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1993.tb06734.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.